Ken Nelson currently serves as Head of Digital Health, Diagnostics, and Monitoring for Biotronik, a leading digital health and medical device company that has been developing trusted and innovative cardiovascular solutions and implantable cardiac devices for more than 50 years.
Over the past 10 years, Ken has led commercial efforts for disruptive technologies in the digital health, wearables, and cardiac remote patient monitoring industries, playing a significant role in building the teams, cultures, and infrastructures for 3 of the top 4 market share players in cardiac digital health and remote patient monitoring, including #1 (BioTelemetry as VP of Sales), #2 (iRhythm as VP of Sales & Marketing), and #4 (Bardy Diagnostics as Chief Commercial Officer).
Overall, he is a 20 year digital health, medical device, and remote patient monitoring executive and innovator with successful senior leadership experience ranging from a Fortune 500 company (Boston Scientific) to a #1 market share leading medium sized company (Biotelemetry, acquisition by Philips for $2.8 Billion announced in December '20) to 3 start-ups, 1 of which eventually led to an extremely successful IPO (iRhythm) and another which was just acquired by HillRom (Bardy Diagnostics) in August 2021 for what will end up being $400M+ after milestone payments. Ken earned a B.A. in Economics from Vanderbilt University and resides in Dallas, TX with his wife and 3 children.